Measurement of cellular immunity in human coccidioidomycosis

Mycopathologia

Volumn 156, Issue 4, 2003, Pages 247-262

  Ampel, Neil M ^a,b  

^a UNIVERSITY OF ARIZONA   (United States)

^b S AZ Vet Aff Health Care System   (United States)

Author keywords

Cellular; Coccidioides; Coccidioidomycosis; Human; Immunity

Indexed keywords

COCCIDIOIDIN; SPHERULIN;

CELLULAR IMMUNITY; COCCIDIOIDES; COCCIDIOIDOMYCOSIS; DELAYED HYPERSENSITIVITY; HUMAN; IMMUNOLOGY; METHODOLOGY; REVIEW; SKIN TEST;

COCCIDIOIDES; COCCIDIOIDIN; COCCIDIOIDOMYCOSIS; HUMANS; HYPERSENSITIVITY, DELAYED; IMMUNITY, CELLULAR; SKIN TESTS;

COCCIDIOIDES; FUNGI;

EID: 0344304566     PISSN: 0301486X     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:MYCO.0000003580.93839.71     Document Type: Review

References (123)

1. Pappagianis D. Epidemiology of coccidioidomycosis. Curr Top Med Mycol 1988; 2: 199-238.
2. Fisher MC, Koenig GL, White TJ, Taylor JW. Molecular and phenotypic description of Coccidioides posadasii sp. nov., previously recognized as the non-California population of Coccidioides immitis. Mycologia 2002; 94(1): 73-84.
3. Galgiani JN. Coccidioidomycosis: a regional disease of national importance. Rethinking approaches for control. Ann Intern Med 1999; 130(4 Pt 1): 293-300.
4. Dickson EC. Coccidioidomycosis. The preliminary acute infection with fungus Coccidioides. JAMA 1938; 111: 1362-1365.
5. Dickson EC. Primary coccidioidomycosis. The initial acute infection which results in coccidioidal granuloma. Am Rev Tuberc 1938; 38: 722-729.
6. Dickson EC, Gifford MA. Coccidioides infection (coccidioidomycosis). II. The primary type of infection. Arch Intern Med 1938; 62: 853-871.
7. Smith CE, Beard R. Varieties of coccidioidal infection in relation to the epidemiology and control of the diseases. Am J Public Health 1946; 36: 1394-1402.
8. Smith CE, Whiting EG, Baker EE, Rosenberger HG, Beard R, Saito MT. The use of coccidioidin. Am Rev Tuberc 1948; 57: 330-360.
9. Cooke JV. Immunity test in coccidioidal granuloma. Arch Intern Med 1915; 15: 479-486.
10. Davis DJ. Coccidioidal granuloma with certain serologic observations. Arch Dermatol 1924; 9: 577-588.
11. Hirsch EF, D'Andrea D. The specific substance of Coccidioides immitis. J Infect Dis 1927; 40: 634-637.
12. Stewart RA, Kimura F. Studies in the skin test for coccidioidal infection. J Infect Dis 1940; 66: 212-217.
13. Hassid WZ, Baker EE, McCready RM. An immunologically active polysaccharide produced by Coccidioides immitis, Rixford and Gilchrist. J Biol Chem 1943; 149: 303-311.
14. Smith CE, Saito MT, Beard RR, Rosenberger HG, Whiting EG. Histoplasmin sensitivity and coccidioidal infection. 1. Occurrence of cross-reactions. Am J Public Health 1949; 39: 722-736.
15. Rapaport FT, Lawrence HS, Millar JW, Pappagianis D, Smith CE. The immunologic properties of coccidioidin as a skin test reagent in man. J Immunol 1960; 84: 368-373.
16. Pappagianis D, Smith CE, Campbell CC. Serologic status after positive coccidioidin skin reactions. Am Rev Respir Dis 1967; 96(3): 520-523.
17. Pappagianis D, Maibach H, Smith CE. Microscopic characteristics of the cutaneous reaction to coccidioidin in humans. Am Rev Respir Dis 1967; 95(2): 317-319.
18. Drutz DJ, Catanzaro A. Coccidioidomycosis. Part I. Am Rev Respir Dis 1978; 117(3): 559-585.
19. Converse JL. Effect of surface active agents on endosporulation of Coccidioides immitis in a chemically defined medium. J Bact 1957; 74: 106-107.
20. Levine BE, Cobb JM, Smith CE. Immunity to Coccidioidomycosis induced mice by purified spherule, arthrospore, and mycelial vaccines. Trans NY Acad Sci 1960; 22: 436-449.
21. Levine BE, Cobb JM, Smith CE. Immunogenicity of spherule-endospore vaccines of Coccidioides immitis for mice. J Immunol 1961; 87: 218-227.
22. Kong YM, Savage DC, Kong LNL. Delayed dermal hypersenstivity in mice to spherule and mycelial extracts of Coccidioides immitis. J Bact 1966; 91: 876-883.
23. Levine HB, Cobb JM, Scalarone GM. Spherule coccidioidin in delayed dermal sensitivity reactions of experimental animals. Sabouraudia 1969; 7: 20-32.
24. Friedman L, Smith CE, Roessler WG, Berman RJ. The virulence and infectivity of twenty-seven strains of Coccidioides immitis. Am J Hyg 1956; 64: 198-210.
25. Levine HB, Gonzalez-Ochoa A, Ten Eyck DR. Dermal sensitivity to Coccidioides immitis. A comparison of responses elicited in man by spherulin and coccidioidin. Am Rev Respir Dis 1973; 107(3): 379-386.
26. Stevens DA, Levine HB, TenEyck DR. Dermal sensitivity to different doses of spherulin and coccidioidin. Chest 1974; 65(5): 530-533.
27. Levine HB, Restrepo-M A, Eyck DR, Stevens DA. Spherulin and coccidioidin: cross-reactions in dermal sensitivity to histoplasmin and paracoccidioidin. Am J Epidemiol 1975; 101(6): 512-516.
28. Stevens DA, Levine HB, Deresinski SC. Spherulin in clinical coccidioidomycosis. Comparison with coccidioidin. Chest 1975; 68: 697-702.
29. Deresinski SC, Levine HB, Kelly PC, Creasman RJ, Stevens DA. Spherulin skin testing and histoplasmal and coccidioidal serology: lack of effect. Am Rev Respir Dis 1977; 116(6): 1116-1168.
30. Gifford J, Catanzaro A. A comparison of coccidioidin and spherulin skin testing in the diagnosis of coccidioidomycosis. Am Rev Respir Dis 1981; 124(4): 440-444.
31. Dodge RR, Lebowitz MD, Barbee R, Burrows B. Estimates of C. immitis infection by skin test reactivity in an endemic community. Am J Public Health 1985; 75(8): 863-865.
32. Dvorak HF, Galli SJ, Dvorak AM. Expression of cell-mediated hypersensitivity in vivo - recent advances. Int Rev Exp Pathol 1980; 21: 119-194.
33. Chu CQ, Field M, Andrew E, Haskard D, Feldmann M, Maini RN. Detection of cytokines at the site of tuberculin-induced delayed-type hypersensitivity in man. Clin Exp Immunol 1992; 90(3): 522-529.
34. Buchanan KL, Murphy JW. Kinetics of cellular infiltration and cytokine production during the efferent phase of a delayed-type hypersensitivity reaction. Immunology 1997; 90(2): 189-197.
35. Lockey RF. Adverse reactions associated with skin testing and immunotherapy Allergy Proc 1995; 16(6): 293-296.
36. Sokal JE. Editorial: Measurement of delayed skin-test responses. N Engl J Med 1975; 293(10): 501-502.
37. Galgiani JN. Development of dermal hypersensitivity to coccidioidal antigens associated with repeated skin testing. Am Rev Respir Dis 1986; 134(5): 1045-1047.
38. Kelley JB, Stanfield AB, Dukes CD, Parsons JL. The in vitro response of human peripheral lymphocytes to coccidioidin. Am Rev Respir Dis 1968; 97(6): 1131-1132.
39. Zweiman B, Pappagianis D, Maibach H, Hildreth EA. Coccidioidin delayed hypersensitivity: skin test and in vitro lymphocyte reactivities. J Immunol 1969; 102(5): 1284-1289.
40. Graybill JR, Alford RH. Variability of sequential studies of lymphocyte blastogenesis in normal adults. Clin Exp Immunol 1976; 25(1): 28-35.
41. Catanzaro A, Spitler LE, Moser KM. Cellular immune response in coccidioidomycosis. Cell Immunol 1975; 15: 360-371.
42. Opelz G, Scheer MI. Cutaneous sensitivity and in vitro responsiveness of lymphocytes in patients with disseminated coccidioidomycosis. J Infect Dis 1975; 132(3): 250-255.
43. Cox RA, Vivas JR, Gross A, Lecara G, Miller E, Brummer E. In vivo and in vitro cell-mediated responses in coccidioidomycosis. I. Immumologic responses of persons with primary, asymptomatic infections. Am Rev Respir Dis 1976; 114(5): 937-943.
44. Cox RA, Vivas JR. Spectrum of in vivo and in vitro cell-mediated immune responses in coccidioidomycosis. Cell Immunol 1977; 31(1): 130-141.
45. Pappagianis D, Smith CE, Kobayashi GS, Saito MT. Studies of antigens from young mycelia of Coccidioides immitis. J Infect Dis 1961; 108: 35-44.
46. Deresinski SC, Levine HB, Stevens DA. Soluble antigens of mycelia and spherules in the in vitro detection of immunity to Coccidioides immitis. Infect Immun 1974; 10(4): 700-704.
47. Cox RA, Brummer E, Lecara G. In vitro lymphocyte responses of coccidioidin skin test-positive and - negative persons to coccidioidin, spherulin, and a coccidioides cell wall antigen. Infect Immun 1977; 15(3): 751-755.
48. Deresinski SC, Applegate RJ, Levine HB, Stevens DA. Cellular immunity to Coccidioides immitis: in vitro lymphocyte response to spherules, arthrospores, and endospores. Cell Immunol 1977; 32: 110-119.
49. Dooley DP, Cox RA, Hestilow KL, Dolan MJ, Magee DM. Cytokine induction in human coccidioidomycosis. Infect Immun 1994; 62(9): 3980-3983.
50. Galgiani JN, Dugger KO, Ampel NM, Sun SH, Law JH. Extraction of serologic and delayed hypersensitivity antigens from spherules of Coccidioides immitis. Diagn Microbiol Infect Dis 1988; 11(2): 65-80.
51. Ampel NM, Bejarano GC, Salas SD, Galgiani JN. In vitro assessment of cellular immunity in human coccidioidomycosis: relationship between dermal hypersensitivity, lymphocyte transformation, and lymphokine production by peripheral blood mononuclear cells from healthy adults. J Infect Dis 1992; 165(4): 710-715.
52. Corry DB, Ampel NM, Christian L, Locksley RM, Galgiani JN. Cytokine production by peripheral blood mononuclear cells in human coccidioidomycosis. J Infect Dis 1996; 174(2): 440-443.
53. Dugger KO, Galgiani JN, Ampel NM, Sun SH, Magee DM, Harrison J, et al. An immunoreactive apoglycoprotein purified from Coccidioides immitis. Infect Immun 1991; 59(7): 2245-2251.
54. Dugger KO, Villareal KM, Ngyuen A, Zimmermann CR, Law JH, Galgiani JN. Cloning and sequence analysis of the cDNA for a protein from Coccidioides immitis with immunogenic potential. Biochem Biophys Res Commun 1996; 218(2): 485-489.
55. Zhu Y, Yang C, Magee DM, Cox RA. Coccidioides immitis antigen 2: analysis of gene and protein. Gene 1996; 181(1-2): 121-125.
56. Zhu Y, Yang C, Magee DM, Cox RA. Molecular cloning and characterization of Coccidioides immitis antigen 2 cDNA. Infect Immun 1996; 64(7): 2695-2699.
57. Kirkland TN, Finley F, Orsborn KI, Galgiani JN. Evaluation of the proline-rich antigen of Coccidioides immitis as a vaccine candidate in mice. Infect Immun 1998; 66(8): 3519-3522.
58. Abuodeh RO, Shubitz LF, Siegel E, Snyder S, Peng T, Orsborn KI, et al. Resistance to Coccidioides immitis in mice after immunization with recombinant protein or a DNA vaccine of a proline-rich antigen. Infect Immun 1999; 67(6): 2935-2940.
59. Zhu Y, Tryon V, Magee DM, Cox RA. Identification of a Coccidioides immitis antigen 2 domain that expresses B-cell-reactive epitopes. Infect Immun 1997; 65(8): 3376-3380.
60. Orsborn KI, Galgiani JN. Detecting serum antibodies to a purified recombinant proline-rich antigen of Coccidioides immitis in patients with coccidioidomycosis. Clin Infect Dis 1998; 27(6): 1475-1478.
61. Zimmermann CR, Johnson SM, Martens GW, White AG, Zimmer BL, Pappagianis D. Protection against lethal murine coccidioidomycosis by a soluble vaccine from spherules. Infect Immun 1998; 66(5): 2342-2345.
62. Ampel NM, Kramer LA, Kerekes KM, Johnson SM, Pappagianis D. Assessment of the human immune response to T27K, a coccidioidal antigen preparation, by flow cytometry of whole blood. Med Mycol 2001; 39: 315-320.
63. Hung CY, Ampel NM, Christian L, Seshan KR, Cole GT. A major cell surface antigen of Coccidioides immitis which elicits both humoral and cellular immune responses. Infect Immun 2000; 68(2): 584-593.
64. Hung CY, Ampel NM, Christian L, Yu JJ, Seshan KR, Cole GT. Characterization and cloning of an immunodominant spherule outer wall antigen of Coccidioides immitis [Abstract 343]. In: 36th Annual Meeting of the Infectious Diseases Society of America; 1998; Denver, CO; 1998.
65. Pappagianis D, Putman EW, Kobayashi GS. Polysaccharide of Coccidioides immitis. J Bact 1961; 82: 714-723.
66. Anderson KL, Wheat RW, Conant NF. Fractionation and composition studies of skin test-active components of sensitins from Coccidioides immitis. Appl Microbiol 1971; 22: 294-299.
67. Wheat RW, Woodruff WW, 3rd, Haltiwanger RS. Occurrence of antigenic (species-specific?) partially 3-O-methylated heteromannans in cell wall and soluble cellular (nonwall) components of Coccidioides immitis mycelia. Infect Immun 1983; 41(2): 728-734.
68. Tzianabos AO. Polysaccharide immunomodulators as therapeutic agents: structural aspects and biologic function. Clin Microbiol Rev 2000; 13: 523-533.
69. Harvey RP, Stevens DA. In vitro assays of cellular immunity in progressive coccidioidomycosis: evaluation of suppression with parasitic-phase antigen. Am Rev Respir Dis 1981; 123(6): 665-669.
70. Cox RA, Pope RM. Serum-mediated suppression of lymphocyte transformation responses in coccidioidomycosis. Infect Immun 1987; 55(5): 1058-1062.
71. Brass C, Levine HB, Stevens DA. Stimulation and suppression of cell-mediated immunity by endosporulation antigens of Coccidioides immitis. Infect Immun 1982; 35(2): 431-436.
72. Barbee RA, Hicks MJ. Clinical usefulness of lymphocyte transformation in patients with coccidioidomycosis. Chest 1988; 93(5): 1003-1007.
73. Oldfield EC, 3rd, Bone WD, Martin CR, Gray GC, Olson P, Schillaci RF. Prediction of relapse after treatment of coccidioidomycosis. Clin Infect Dis 1997; 25(5): 1205-1210.
74. Ampel NM, Christian L. In vitro modulation of proliferation and cytokine production by human peripheral blood mononuclear cells from subjects with various forms of coccidioidomycosis. Infect Immun 1997; 65(11): 4483-4487.
75. Catanzaro A. Suppressor cells in coccidioidomycosis. Cell Immunol 1981; 64(2): 235-245.
76. Cox RA, Kennell W. Suppression of T-lymphocyte response by Coccidioides immitis antigen. Infect Immun 1988; 56(6): 1424-1429.
77. Smith CE. Epidemiology of acute coccidioidomycosis with erythema nodosum ("San Joaquin" or "Valley Fever"). Am J Public Health 1940; 30: 600-611.
78. Larwood TR. Coccidioidin skin testing in Kern County, California: decrease in infection rate over 58 years. Clin Infect Dis 2000; 30(3): 612-613.
79. Catanzaro A. Coccidioidin sensitivity in San Diego schools. Sabouraudia 1979; 17(2): 85-89.
80. Aronson JD, Saylor RM, Parr EI. Relationship of coccidioidomycosis to calcified pulmonary nodules. Arch Pathol 1942; 34: 31-48.
81. Doto IL, Tosh FE, Farnsworth SF, Furcolow ML. Coccidioidin, histoplasmin, and tuberculin sensitivity among school children in Maricopa County, Arizona. Am J Epidemiol 1972; 95(5): 464-474.
82. Geller RD, Maynard JE, Jones V. Coccidioidin sensitivity among Southwestern American Indians. Am Rev Respir Dis 1973; 107(2): 301-302.
83. Edwards PQ, Palmer CE. Prevalence of sensitivity to coccidioidin, with special reference to specific and nonspecific reactions to coccidioidin and histoplasmin. Dis Chest 1957; 31: 35-60.
84. Padua y Gabriel A, Martinez-Ordaz VA, Velasco-Rodreguez VM, Lazo-Saenz JG, Cicero R. Prevalence of skin reactivity to coccidioidin and associated risks factors in subjects living in a northern city of Mexico. Arch Med Res 1999; 30(5): 388-392.
85. Islam N, Sobhan MA. Sensitivity to histoplasmin, coccidioidin, blastomycin, and tuberculin in East Pakistan. Am J Trop Med Hyg 1971; 20(4): 621-624.
86. Bezjak V, Farsey SJ. Prevalence of skin sensitivity to histoplasmin and coccidioidin in varous Ugandan populations. Am J Trop Med Hyg 1970; 19(4): 664-669.
87. Brown P, Cathala F, Gajdusek DC. Mycobacterial and fungal skin sensitivity patterns among remote population groups in Papua New Guinea, and in the New Hebrides, Solomon, and Caroline Islands. Am J Trop Med Hyg 1981; 30(5): 1085-1093.
88. Baum GL, Wu JN, Hua SS, Baum C, Ajello L. Skin sensitivity to histolyn, spherulin, and PPD in the People's Republic of China. Chest 1990; 97(6): 1356-1359.
89. Woodruff WW, 3rd, Buckley CE, 3rd, Gallis HA, Cohn JR, Wheat RW. Reactivity to spherule-derived coccidioidin in the southeastern United States. Infect Immun 1984; 43(3): 860-869.
90. Winn WA, Levine BE, Broderick JE, Crane RW. A localized epidemic of coccidioidal infection. N Engl J Med 1963; 268: 867-870.
91. Teel KW, Yow MD, Williams TW, Jr. A localized outbreak of coccidioidomycosis in southern Texas. J Pediatr 1970; 77(1): 65-73.
92. Roberts PL, Lisciandro RC. A community epidemic of coccidioidomycosis. Am Rev Respir Dis 1967; 96(4): 766-772.
93. Ramras DG, Walch HA, Murray JP, Davidson BH. An epidemic of coccidioidomycosis in the Pacific beach area of San Diego. Am Rev Respir Dis 1970; 101(6): 975-978.
94. Rao S, Biddle M, Balchum OJ, Robinson JL. Focal endemic coccidioidomycosis in Los Angeles County. Am Rev Respir Dis 1972; 105(3): 410-416.
95. Loofbourow JC, Pappagianis D, Cooper TY. Endemic coccidioidomycosis in Northern California. An outbreak in the Capay Valley of Yolo County. Calif Med 1969; 111(1): 5-9.
96. Werner SB, Pappagianis D, Heindl I, Mickel A. An epidemic of coccidioidomycosis among archeology students in northern California. N Engl J Med 1972; 286: 507-512.
97. Werner SB, Pappagianis D. Coccidioidomycosis in Northern California. An outbreak among archeology students near Red Bluff. Calif Med 1973; 119(3): 10-20.
98. Fiese MJ. Coccidioidomycosis. Springfield, IL: Charles C. Thomas, Publisher; 1958.
99. Wiant JR, Smith JW. Coccidioidin skin reactivity in pulmonary coccidioidomycosis. Chest 1973; 63(1): 100-102.
100. Ampel NM, Kramer LA, Li L, Carroll DS, Kerekes KM, Johnson SM, et al. In vitro whole blood analysis of cellular immunity in coccidioidomycosis. Clin Diagn Lab Immunol 2002; 9(5): 1039-1043.
101. Ampel NM, Christian L. How cytometric assessment of human peripheral blood mononuclear cells in response to a coccidioidal antigen. Med Mycol 2000; 38(2): 127-132.
102. Ampel NM, Dols CL, Galgiani JN. Coccidioidomycosis during human immunodeficiency virus infection: results of a prospective study in a coccidioidal endemic area. Am J Med 1993; 94(3): 235-240.
103. Ampel NM. Delayed-type hypersensitivity, in vitro T-cell responsiveness and risk of active coccidioidomycosis among HIV-infected patients living in the coccidioidal endemic area. Med Mycol 1999; 37(4): 245-250.
104. Hicks MJ, Hagaman RM, Barbee RA. Evaluation of methodologic variables of the in vitro lymphocyte transformation assay. Am J Clin Pathol 1986; 85(6): 704-709.
105. Hicks MJ, Hagaman RM, Barbee RA. The prevalence of cellular immunity to coccidioidomycosis in a highly endemic area. West J Med 1986; 144(4): 425-428.
106. Barbee RA, Hicks MJ, Grosso D, Sandel C. The maternal immune response in coccidioidomycosis. Is pregnancy a risk factor for serious infection? Chest 1991; 100(3): 709-715.
107. Levine HB, Miller RL, Smith CE. Influence of vaccination on respiratory coccidioidal disease in Cynomolgous monkeys. J Immunol 1962; 89: 242-251.
108. Williams PL, Sable DL, Sorgen SP, Pappagianis D, Levine HB, Brodine SK et al. Immunologic responsiveness and safety associated with the Coccidioides immitis spherule vaccine in volunteers of white, black, and Filipino ancestry. Am J Epidemiol 1984; 119(4): 591-602.
109. Pappagianis D. Evaluation of the protective efficacy of the killed Coccidioides immitis spherule vaccine in humans. The Valley Fever Vaccine Study Group. Am Rev Respir Dis 1993; 148(3): 656-660.
110. Pappagianis D. Seeking a vaccine against Coccidioides immitis and serologic studies: expectations and realities. Fungal Genet Biol 2001; 32(1): 1-9.
111. Kirkpatrick CH. Transfer factors: identification of conserved sequences in transfer factor molecules. Mol Med 2000; 6(4): 332-341.
112. Rapaport FT, Lawrence HS, Millar JW, Pappagianis D, Smith CE. Transfer of delayed hypersensitivity to coccidioidin in man. J Immunol 1960; 84: 358-367.
113. Graybill JR, Silva J, Jr., Alford RH, Thor DE. Immunologic and clinical improvement of progressive coccidioidomycosis following administration of transfer factor. Cell Immunol 1973; 8(1): 120-135.
114. Catanzaro A, Spitler L, Moser KM. Immunotherapy of coccidioidomycosis. J Clin Invest 1974; 54(3): 690-701.
115. Stevens DA, Pappagianis D, Marinkovich VA, Waddell TF. Immunotherapy in recurrent coccidioidomycosis. Cell Immunol 1974; 12(1): 37-48.
116. Cloninger P, Thrupp LD, Granger GA, Novey HS. Immunotherapy with transfer factor in disseminated coccidioidal osteomyelitis and arthritis. West J Med 1974; 120(4): 322-325.
117. Steele RW, Sieger BE, McNitt TR, Gentry LO, Moore WL, Jr. Therapy for disseminated coccidioidomycosis with transfer factor from a related donor. Am J Med 1976; 61(2): 283-286.
118. Drutz DJ, Catanzaro A. Coccidioidomycosis. Part II. Am Rev Respir Dis 1978; 117(4): 727-771.
119. Rea TH, Einstein H, Levan NE. Dinitrochlorobenzene responsivity in disseminated coccidioidomycosis: an inverse correlation with complement-fixing antibocy titers. J Invest Dermatol 1976; 66: 34.
120. Burch WM, Snyderman R. Induction of cellular immunity to Coccidioides immitis after sensitization with dinitrochlorobenzene. Ann Intern Med 1982; 96(3): 329-331.
121. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000; 18: 767-811.
122. Richards JO, Ampel NM, Galgiani JN, Lake DF. Dendritic cells pulsed with Coccidioides immitis lysate induce antigen-specific naive T cell activation. J Infect Dis 2001; 184(9): 1220-1224.
123. Richards JO, Ampel NM, Lake DF. Reversal of C. immitis-specific energy by dendritic cells from patients with disseminated coccidioidomycosis. J Immunol 2002; 169(4): 2020-2025.